Trial NCT04341441

View at ClinicalTrials.gov 
Org. Study IDs: 1410401

Last trial update was posted on 2022-06-21

MeSH Interventions

Hydroxychloroquine

MeSH Conditions

COVID-19 Coronavirus Infections

Other Conditions

Coronavirus SARS-CoV 2

Stopping Reasons

Interim analysis did not reveal any safety concerns by the DSMB, but unblinded data did not provide support to continue. Event rate did not meet projected magnitude; given low recruitment potential, it is unlikely that a positive result will occur.

Limitations And Caveats

Study has been terminated. Interim analysis did not reveal any safety concerns by the DSMB with hydroxychloroquine treatment, but unblinded data did not provide support to continue due to low numbers of events. Event rate did not meet projected magnitude; given low recruitment potential, it is unlikely that a positive result will occur.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID